KIRA Uterine Drain Device Evaluation- First-In- Human Study

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Lucie Medical Inc
Study ID
NCT07387380
Status
Completed

Conditions

  • Cesarean Delivery Procedures

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Uterine drain for use in cesarean section — DEVICE
    The intervention will be used to remove uterine contents and measure blood loss immediately following cesarean delivery.

Study Details

The purpose of this research is to evaluate a new investigational medical device, the Kira device, intended to make it easier for the surgical team to monitor blood loss during and immediately after cesarean deliveries (c-sections). This study will assess the safety of the device and the device's ability to gently suction blood from the uterus into a clear container where it can be seen and measured by the surgical team.

Key Dates

Start date
Jan 6, 2026
Status verified
May 2026
Primary completion
Apr 5, 2026
Completion
Apr 5, 2026

Study Design

Enrollment
10 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Interventional
    All participants will be assigned to the interventional arm, in which the uterine drain is used to evaluate the blood loss immediately following cesarean delivery.

Primary Outcome Measure

Incidence, severity and seriousness of device related Adverse Events (ADE's) [ Time Frame: Measured at study exit, approximately 3 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
Ohio State UniversityColumbusOhio43210-

Find similar trials in Columbus, OH